Red Light, Green Light: Oral Methimazole for Feline Hyperthyroidism

Sponsored by Virbac
Hyperthyroidism is a common feline endocrinopathy that primarily affects middle-aged to older cats. The most common cause is development of adenomatous hyperplasia or functional thyroid adenoma(s) within the thyroid tissue, which results in excess production of triiodothyronine (T3) and thyroxine (T4).1 Excess thyroid hormone can cause a variety of clinical signs, including weight loss, polyphagia, poor haircoat, vomiting, hyperactivity, aggression, and/or excessive vocalization.1
Feline hyperthyroidism can have serious consequences, including death, if left untreated. Treatment options include radioactive iodine (I-131) as the gold-standard curative treatment,2 surgical thyroidectomy, an iodine-restricted prescription diet, or medical treatment with methimazole. Historically, options for methimazole have been limited to tablets and compounded formulations; however, in 2024, the FDA approved Felanorm® (methimazole) Oral Solution in the United States, expanding options for treatment.
IMPORTANT SAFETY INFORMATION
Felanorm® (methimazole) Oral Solution: As with all methimazole products, wear protective single use, impermeable (e.g., latex or nitrile) gloves when administering the solution. The most commonly reported side effects in cats are anorexia, vomiting, head/facial pruritus or edema, depression/lethargy, weight loss, anemia, elevated liver enzymes, skin lesions, elevated BUN, diarrhea, and thrombocytopenia. In some reported cases, the patients recovered after adverse reactions were recognized, the drug was withdrawn, and veterinary care was applied. Methimazole has anti-vitamin K activity and may induce bleeding diathesis without evidence of thrombocytopenia. Not for use in pregnant or lactating queens. Not for use in cats with primary renal or hepatic failure, autoimmune disease, or with hematological disorders (see the full prescribing information for additional details). For full prescribing information, contact VIRBAC at 1-800-338-3659 or click here.
